CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target (Q37826381)

23 August 2017

1 reference

title

CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target (English)

1 reference

23 August 2017

1 reference

1 reference

Mizuhiko Terasaki

1

1 reference

23 August 2017

Yasuo Sugita

2

1 reference

23 August 2017

Fumiko Arakawa

3

1 reference

23 August 2017

Yosuke Okada

4

1 reference

23 August 2017

Koichi Ohshima

5

1 reference

23 August 2017

Minoru Shigemori

6

1 reference

23 August 2017

6 January 2011

1 reference

23 August 2017

Brain Tumor Pathology

1 reference

23 August 2017

28

1 reference

23 August 2017

2

1 reference

23 August 2017

89-97

1 reference

https://scigraph.springernature.com/pub.10.1007/s10014-010-0013-1

23 August 2017

0 references

cites work

CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

CXCL12 (SDF-1)/CXCR4 pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

SDF1/CXCR4 signalling regulates two distinct processes of precerebellar neuronal migration and its depletion leads to abnormal pontine nuclei formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

CXCL13 and CXCL12 in central nervous system lymphoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Nestin, PDGFRbeta, CXCL12 and VEGF in glioma patients: different profiles of (pro-angiogenic) molecule expression are related with tumor grade and may provide prognostic information.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

CXCL12-mediated induction of plasminogen activator inhibitor-1 expression in human CXCR4 positive astroglioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Expression of tubulin beta II in neuroepithelial tumors: reflection of architectural changes in the developing human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Expression of stem cell markers in human astrocytomas of different WHO grades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

CXCR4 mediates the proliferation of glioblastoma progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10014-010-0013-1

10.1007/S10014-010-0013-1

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference